Food and Drug Administration Safety and Innovation Act (FDASIA)

The Food and Drug Administration Safety and Innovation Act (FDASIA), enacted in 2012, is a law that enhances the FDA’s ability to oversee the safety and effectiveness of drugs, vaccines, and medical devices. It provides the agency with more resources and authority to speed up the development and review processes of new treatments, ensure better safety monitoring, and improve public health. The law also supports innovation and addresses challenges in the healthcare system, promoting faster access to new medical products while maintaining high safety standards.